4.7 Article

Prodigiosin down-regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Lung Cancer: New Biological Insights and Recent Therapeutic Advances

Suresh S. Ramalingam et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Review Pharmacology & Pharmacy

Targeting p27Kip1 protein: its relevance in the therapy of human cancer

Adriana Borriello et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2011)

Article Biochemistry & Molecular Biology

SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1 through SKP2 in Human Leukemia Cells

Gabriel Bretones et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Review Biotechnology & Applied Microbiology

Development of natural anti-tumor drugs by microorganisms

Chia-Che Chang et al.

JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2011)

Article Medicine, General & Internal

Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib

Vince D. Cataldo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Pharmacology & Pharmacy

Targeting epidermal growth factor receptor: Central signaling kinase in lung cancer

Takeshi Yoshida et al.

BIOCHEMICAL PHARMACOLOGY (2010)

Review Biochemistry & Molecular Biology

New Insights on the Antitumoral Properties of Prodiginines

R. Perez-Tomas et al.

CURRENT MEDICINAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

Hui-Kuan Lin et al.

NATURE (2010)

Article Medicine, General & Internal

Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.

Makoto Maemondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Environmental Sciences

Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression

Chia-Hsin Chan et al.

THESCIENTIFICWORLDJOURNAL (2010)

Review Pharmacology & Pharmacy

Prodigiosins as Anti Cancer Agents: Living Upto Their Name

R. Pandey et al.

CURRENT PHARMACEUTICAL DESIGN (2009)

Article Medicine, Research & Experimental

Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer

Shahab Uddin et al.

LABORATORY INVESTIGATION (2009)

Article Cell Biology

Skp2: caught in the Akt

Karin Ecker et al.

NATURE CELL BIOLOGY (2009)

Article Pharmacology & Pharmacy

Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines

Tsing-Fen Ho et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)

Article Endocrinology & Metabolism

EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein

Hsiu-Chen Huang et al.

ENDOCRINOLOGY (2008)

Article Pharmacology & Pharmacy

The anticancer agent prodigiosin induces p21WAF1/C1P1 expression via transforming growth factor-beta receptor pathway

Vanessa Soto-Cerrato et al.

BIOCHEMICAL PHARMACOLOGY (2007)

Review Microbiology

The biosynthesis and regulation of bacterial prodiginines

Neil R. Williamson et al.

NATURE REVIEWS MICROBIOLOGY (2006)

Article Biochemistry & Molecular Biology

F-box protein Skp2: a novel transcriptional target of E2F

L Zhang et al.

ONCOGENE (2006)

Article Oncology

Significance of Skp2 expression in primary breast cancer

H Sonoda et al.

CLINICAL CANCER RESEARCH (2006)

Article Multidisciplinary Sciences

Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase

T Bashir et al.

NATURE (2004)

Article Cell Biology

Skp2-mediated degradation of p27 regulates progression into mitosis

K Nakayama et al.

DEVELOPMENTAL CELL (2004)